Bright Minds Biosciences (DRUG) Change in Cash (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Change in Cash of $159.9 million for Q1 2026, up 2842.94% on a QoQ basis from $5.4 million in Q4 2025, and up 10526.73% year-over-year from N/an in Q1 2025.
Bright Minds Biosciences (DRUG) Change in Cash (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Change in Cash history runs 7 years deep, the most recent figure standing at $159.9 million for Q1 2026.
- Quarterly Change in Cash rose 10526.73% year-over-year to $159.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186.0 million (up 439.97% YoY) and the FY2025 annual result came in at $55.9 million, up 7429.91% from the prior year.
- Change in Cash was $159.9 million for Q1 2026 at Bright Minds Biosciences, up from $5.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $159.9 million in Q1 2026 and bottomed at -$15.1 million in Q3 2022.
- A 5-year average of $12.1 million and a median of $159537.1 in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash jumped 87934.57% — and 2025, when it tumbled 1692.74%.
- Bright Minds Biosciences' Change in Cash stood at -$301578.2 in 2022, then surged by 113.63% to $41101.7 in 2023, then soared by 87934.57% to $36.2 million in 2024, then tumbled by 84.99% to $5.4 million in 2025, then soared by 2842.94% to $159.9 million in 2026.
- Business Quant data shows DRUG's Change in Cash at $159.9 million in Q1 2026, $5.4 million in Q4 2025, and $23.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | 159.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159.86 Mn |
| Dec 31, 2025 | 5.43 Mn |
| Sep 30, 2025 | 23.29 Mn |
| Jun 30, 2025 | -2.54 Mn |
| Mar 31, 2025 | -1.53 Mn |
| Dec 31, 2024 | 36.18 Mn |
| Sep 30, 2024 | -356,796.89 |
| Jun 30, 2024 | 159,537.06 |
| Mar 31, 2024 | -613,761.76 |
| Dec 31, 2023 | 41,101.67 |
| Sep 30, 2023 | -6.30 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | -301,578.19 |
| Sep 30, 2022 | -15.12 Mn |
| Jun 30, 2022 | 2.24 Mn |
| Mar 31, 2022 | 2.88 Mn |
| Dec 31, 2021 | 3.83 Mn |
| Sep 30, 2021 | -1.91 Mn |
| Jun 30, 2021 | -2.86 Mn |